Cafeteria diet increases prostaglandin e2 levels in rat prostate, kidney and testis

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 4, 2010, Pages 1073-1078

  Brunetti, L ^a   Leone, S ^a   Chiavaroli, A ^a   Orlando, G ^a   Recinella, L ^a   Ferrante, C ^a   Di Nisio, C ^a   Verratti, V ^a   Vacca, M ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cafeteria diet; Kidney; Polyunsaturated fatty acids; Prostaglandin E2 prostate; Testis

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROSTAGLANDIN E2; CYCLOOXYGENASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAFETERIA DIET; CALORIC INTAKE; DIET; FAT INTAKE; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAT; TESTIS; WEIGHT GAIN; WISTAR RAT; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; METABOLISM;

ANIMALS; CYCLOOXYGENASE 2; DIETARY FATS; DINOPROSTONE; KIDNEY; MALE; ORGAN SPECIFICITY; PROSTATE; RATS; RATS, WISTAR; TESTIS;

EID: 79953019349     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300411     Document Type: Article

References (35)

1. Slacewicz-Sapunlzakis M, Borthakur G, Bums JL, Bo wen PE. Corrélations of dietary patterns with prostate health. Mol Nutr Food Res 2008; 52:114-30.
2. Caruso C, Lio D, Cavallone L, Franceschi C. Aging, longevity, inflammation, and cancer. Ann NY Acad Sci 2004; 1028:1-13.
3. Using AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007; 86:843-57.
4. Ablin RJ, Shaw MW. Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res 1986; 6:327-28.
5. Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993; 122:518-23.
6. Wang D, Dubois RN. Cyclooxygenase-2: a potential target in breast cancer. Setnin Oncol 2004 ; 31:64-73.
7. McLemore TL, Hubbard WC, Litterst CL, Liu MC, Miller S, McMahon NA, Cggleston JC, Boyd MR. Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res 1998;48:3140-7.
8. Robinson LE, Buchholz AC, Mazurak VC. Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome. Appl Physiol NutrMetab 2007; 32:1008-24.
9. Browning LM. n-3 polyunsaturated fatty acids, inflammation and obesity-related disease. Proc Nutr Soc 2003;62:447-53
10. Riediger ND, Olhman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009; 109: 668-79.
11. Gupta S, Srivastava M, Ahmad N, Bostwick DG, Mukhtar H. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 2000; 42: 73-8.
12. Rose DP, Boyer AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 1986; 8:2363-71.
13. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 2006; 83:1483-93.
14. Ting SM, Nair H, Ching I, Taheri S, Dasgupla I. Overweight, obesity and chronic kidney disease. Nephron Clin Pract 2009; 112:121-7.
15. Chow WH, Gridley G, Fraumeni JF Jr. Järvholtn B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000; 343:1305-11.
16. Menghini L, Genovese S, Epifano F, Tirillini B, Fen-ante C, Leporini L. Antiproliferative, protective and antioxidant effects of artichoke, dandelion, turmeric and rosemary extracts and their formulation. Ini J Immunopathol Pharmacol 2010; 23:601-10.
17. Friedman JM, Ilalaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395:763-70.
18. Brunetti L, Orlando G, Michelotto B, Ragazzoni E, Vacca M. Leptin stimulates prostaglandin E2 and F2a, but not nitric oxide production in neonatal rat hypothalamus. Eur J Pharmacol 1999; 369:299-304.
19. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7.
20. Dubois RN, Abramson SB, Crofford L, et al. Cyclüoxygenase in biology and disease. FASEB J 1998; 12:1063-73.
21. Lin DW, Nelson PS. The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinoma. Clin Prostate Cancer 2003; 2: 119-26.
22. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA 2003; 100:1751-56.
23. Liu XJ1, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, et al. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem Biophys Res Commun 2002; 290:249-55.
24. Chaudry AA, Wahle KW, McClinton S, Moffat LE. Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors. Int J Cancer 1994; 57:176-80.
25. Reese AC, Fradet V, Witte JS. Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer. J Nutrigenet Nutrigenomics 2009; 2:149-58.
26. Kobayashi N, Barnard RJ, Henning SM, et al. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res 2006; 12:4662-70.
27. Chen Q, Shinohara N.Abe T, WatanabeT, Nonomura K, Koyanagi T Significance of COX-2 expression in human renal cell carcinoma cell lines. Int J Cancer 2004; 108:825-32.
28. MunganMU, Gurel D, CandaAE, Tuna B, Yorukoglu K, Kirkali Z. Expression of COX-2 in normal and py el o nephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma. Eur Urol 2006; 50:92-7.
29. McCabe AJ, Wallace JM, Gilmore WS, McGlynn H, Strain SJ. Docosahexaenoic acid reduces in vitro invasion of renal cell carcinoma by elevated levels of tissue inhibitor of metalloproteinase-1. J Nutr Biochem 2005; 16:17-22.
30. Menetrier-Caux C, Bain C, Favrot MC, Duc A, Blay JY. Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes. Br J Cancer 1999; 79:119-30.
31. Bonner MR, McCann SE, Moysich KB. Dietary factors and the risk of testicular cancer. Nutr Cancer 2002;44:35-43.
32. Didolkar AK, Roychowdhury D. Effect of prostaglandins A-I, E-2 and F-2 alpha on spennatogenesis in rats. J Reprod Fértil 1980; 58: 275-8.
33. Winnall WR, Ali U, O'Bryan MK, et al. Constitutive expression of prostaglandin-endoperoxide synthase 2 by somatic and spermatogenic cells is responsible for prostaglandin E2 production in the adult rat testis. Biol Reprod 2007; 76:759-68.
34. Hase T, Yoshimura R, Matsuyama M, et al. Cyclooxygenase-1 and -2 in human testicular tumours. Eur J Cancer 2003; 39:2043-9.
35. Dieckmann KP, Hartmann JT, Classen J, Diedenchs M, Pichlmeier U. Is increased body mass index associated with the incidence of testicular germ cell cancer? J Cancer Res Clin Oncol 2009; 135:731-8.